Timothy G. Youngquist 2020 Irrevocable Trust 13D and 13G filings for Coherus Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:04 am Purchase | 2026-03-31 | 13G | COHERUS ONCOLOGY, INC. CHRS | Timothy G. Youngquist 2020 Irrevocable Trust | 12,750,800 8.300% | 12,750,800 (New Position) | Filing |
| 2026-05-11 09:21 am Sale | 2026-02-05 | 13G | COHERUS ONCOLOGY, INC. CHRS | Timothy G. Youngquist 2020 Irrevocable Trust | 0 0.000% | -7,850,800 (Position Closed) | Filing |
| 2026-02-05 10:25 am Purchase | 2026-02-05 | 13G | COHERUS ONCOLOGY, INC. CHRS | Timothy G. Youngquist 2020 Irrevocable Trust | 7,850,800 6.500% | 7,850,800 (New Position) | Filing |